Cellanome is developing an automated multi-omics platform that enables high-throughput live cell phenotypic and functional assays, allowing researchers to observe individual cell behaviors and interactions across various stimuli. This technology provides a granular understanding of cellular heterogeneity, facilitating the exploration of diverse cell types and functions without the need for multiple platforms or additional samples.

Clear Labs is a biotechnology firm that utilizes a genomics system to enhance diagnostic accuracy in clinical and application sectors. The company addresses the complexity of traditional diagnostic processes by providing streamlined genomic analysis, enabling faster and more reliable results.

This startup offers a centralized platform for public health programs, streamlining healthcare logistics for testing, screening, treatment, and referrals. Their model aims to improve equitable healthcare delivery across entire populations by providing core capabilities to health programs and public health departments.

The startup operates a health technology platform that utilizes proprietary sensing technology, including patented hardware and AI algorithms, to enhance the quality and depth penetration of medical diagnostic ultrasounds. This technology enables healthcare providers to obtain clearer images, improving diagnostic accuracy and patient outcomes in medical imaging.

Encoded develops a genetic‑medicine platform that uses precise cellular targeting and advanced gene‑regulation techniques to create one‑time gene therapies for neurological disorders. By identifying unique genetic signatures of disease‑relevant cells, the platform delivers therapeutic payloads with high specificity, improving potency and reducing off‑target effects for both monogenic and broader neurodegenerative conditions.

insitro utilizes machine learning and high-throughput biology to create predictive in vitro human cell-derived disease models, enabling precise identification of therapeutic insights across various diseases. This approach addresses the challenges of high costs and inefficiencies in traditional drug discovery, facilitating faster and more effective development of new medicines.

KavAI provides Active Physical Intelligence™, an AI platform for real-time, hypothesis-driven reasoning in industrial environments. It enables proactive monitoring and predictive management of complex physical systems to prevent failures, enhance safety, and minimize environmental impact.

One Concern provides a data platform that quantifies physical risks to businesses by utilizing AI and catastrophe modeling to create a digital twin of the physical world. This technology enables financial services, insurance, and real estate sectors to measure and benchmark vulnerabilities to operational disruptions, facilitating informed decision-making amidst climate-related uncertainties.

The startup develops a digital healthcare platform featuring a pocket-sized ultrasound probe that provides wireless imaging services. This technology enhances the patient experience by enabling healthcare providers to deliver timely and accurate diagnostic imaging without the constraints of traditional equipment.

Wisdo is an AI-driven social health platform that connects users with personalized peer support and skill-building groups to combat loneliness and social isolation. By leveraging clinically-proven methodologies, Wisdo improves mental health outcomes, reporting a 60% reduction in loneliness and a $1,900 annual medical cost reduction per user.